Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage SNYR Q1 2026 Earnings Significant EPS Miss Amid Lack of Revenue Disclosure SLRC Q1 2026 Earnings Investment Income Misses Expectations as Stock Declines DDI Q1 2026 Earnings Strong EPS Surprise Lifts Results Despite Market Pullback PAYC Q1 2026 Earnings EPS Beat Drives Cautious Sentiment Avalo Therapeutics AVTX Slips 15 as Stock Consolidates Between Key Support and Resistance Jaguar Health JAGX Drops 12 Navigating Key Support Near 29 SolarEdge Technologies SEDG Dips 216 as Resistance Holds Support Levels in Focus Kyverna Therapeutics KYTX Faces Selling Pressure as Stock Nears Key Support at 824 Newmark Group NMRK Shows Modest Decline Amid Sector Headwinds DexCom DXCM Pulls Back 243 as Stock Approaches Key Support Level Vera Therapeutics VERA Edges Lower as Stock Consolidates Near Key Resistance Level GHY Holds Steady Near 120 as HighYield Bond Fund Consolidates in Tight Range Essential Utilities WTRG Posts Modest Gains Approaches Key Resistance at 3927 LEIFRAS Surges Nearly 95 Whats Behind the Massive Move in LFS Shares Doximity Inc DOCS Q1 2026 Earnings EPS Misses Estimates Stock Still Rises